MIG Activators
MIG is commonly known as Monokine Induced by Gamma Interferon (MIG), which is a chemokine also referred to as CXCL9. Chemokines are not typically the kind of proteins that have activators in the traditional sense, as they function by binding to receptors on cell surfaces. However, if you are referring to a different, less well-characterized protein that goes by the acronym MIG and which could be activated by certain chemicals, a detailed description would follow the general principles of protein activation and signaling modulation.
For any protein activation, including MIG activators, such chemicals would interact with the protein to enhance its natural function. Activation can be achieved through direct binding to the protein, promoting a conformational change that results in an increase in its activity. This could mean facilitating the protein's ability to interact with its substrates or enhancing its affinity for other binding partners that are critical for its function. Indirect activators might function by increasing the synthesis of the MIG protein, either by upregulating the transcription of its gene or by stabilizing its mRNA to allow for more translation. In addition, indirect activators could inhibit negative regulators of MIG, such as proteins that target MIG for degradation, or competitive inhibitors that prevent MIG from exerting its function. By blocking these inhibitory pathways, the activators would result in higher functional levels of the MIG protein.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate (S1P) influences the S1P receptor signaling pathway. This pathway modulates chemotaxis and lymphocyte trafficking, indirectly affecting MIG/CXCL9, a chemokine involved in immune cell migration. | ||||||
LTB4 (Leukotriene B4) | 71160-24-2 | sc-201043 | 50 µg | $374.00 | 4 | |
Leukotriene B4 (LTB4) activates the LTB4 receptor, which can stimulate chemotactic responses. This indirectly influences MIG/CXCL9, which is also involved in chemotactic responses. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) influences the prostaglandin signaling pathway, which plays a role in inflammation and immune response, potentially affecting the expression and function of MIG/CXCL9. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
Tacrolimus, like Cyclosporin A, inhibits calcineurin leading to the prevention of NFAT activation and potentially modulates MIG/CXCL9 expression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone, a corticosteroid, modulates the glucocorticoid receptor pathway, which can regulate the transcription of MIG/CXCL9 and influence its expression. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates the JNK pathway and p38 MAPK, both involved in stress responses. As MIG/CXCL9 can be induced by cellular stress, this can lead to increased expression. | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $96.00 $160.00 $240.00 $405.00 | 26 | |
Capsaicin activates the TRPV1 ion channel, leading to increased calcium influx and activation of NFAT, which can regulate the transcription of MIG/CXCL9. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid modulates the retinoic acid receptor pathway, which can influence the transcription of MIG/CXCL9 and its subsequent expression. | ||||||
Anakinra | 143090-92-0 | sc-507486 | 10 mg | $811.00 | ||
Anakinra is an IL-1 receptor antagonist that modulates the inflammatory response, potentially affecting the expression of MIG/CXCL9, which is involved in immune response. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases cAMP levels, activating the cAMP-dependent signaling pathway, which can influence the expression of MIG/CXCL9. | ||||||